The strategic partnership aims to expand the scope and productivity of specialty lab testing retained by Jefferson and further the academic and research missions of Thomas Jefferson University, Labcorp said in a May 3 news release.
“This strategic relationship enables Jefferson to leverage Labcorp’s wide-range of laboratory services, which will help deliver improved outcomes for our patients and optimal service to providers,” Jefferson CEO Joseph Cacchione, MD, said. “This collaboration is another example of our continued efforts to provide critical healthcare solutions that will better serve the community and advance Jefferson’s academic and research missions.”
Labcorp said in February it sees hospital lab acquisitions as an opportunity for growth, with more health systems looking to sell their lab businesses or sign management agreements.
The transaction is expected to close by mid-2023. Financial terms of the deal were not disclosed.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
